Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
sodium chloride + magnesium chloride + calcium chloride + sodium acetate anhydrous + potassium chloride
- Development stage
- Unknown
- Lead developer
- Pfizer
- Modality
- Small Molecules
- Administration
- Intravenous
01
Overview
A sterile **multiple-electrolyte intravenous concentrate** containing sodium chloride, magnesium chloride, calcium chloride, sodium acetate anhydrous, and potassium chloride, marketed as **TPN Electrolytes** by Hospira and now associated with Pfizer's hospital portfolio. It is intended for **intravenous use only after dilution** as an additive to total parenteral nutrition solutions containing concentrated dextrose and amino acids, primarily to maintain or replenish electrolyte balance in adults receiving central venous nutrition support. Its mechanism is physiologic electrolyte replacement: it supplies **sodium, potassium, calcium, magnesium, chloride, and acetate** to support fluid, acid-base, neuromuscular, and cellular homeostasis, with acetate serving as a bicarbonate precursor after metabolism. It is a **small-molecule inorganic salt combination product**, not a biologic, and is used for electrolyte supplementation rather than target-selective pharmacology.
- Brand names
- TPN Electrolytes
- Other names
- multiple electrolyte additivetotal parenteral nutrition electrolytes
Beyond the preview
Go deeper on sodium chloride + magnesium chloride + calcium chloride + sodium acetate anhydrous + potassium chloride.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on sodium chloride + magnesium chloride + calcium chloride + sodium acetate anhydrous + potassium chloride.